NEW YORK, April 24, 2024 /PRNewswire/ Synaptogenix, Inc. , an emerging biopharmaceutical company developing therapeutics for neurodegenerative disorders, today announced that it received notice.
12.04.2024 - WOODCLIFF LAKE, N.J., April 12, 2024 (GLOBE NEWSWIRE) - Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (the “Company”) today announced that it received a notice (the “Notice”) on April 8, 2024 from the Listing Qualifications Department of The Nasdaq . Seite 1
Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
11.03.2024 - ZURICH, SWITZERLAND / ACCESSWIRE / March 11, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ( NLS or the Company ), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for . Seite 1
NLS Pharmaceutics AG: Nasdaq Accepts NLS Pharmaceutics' Plan to Regain Listing Compliance finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.